Suppr超能文献

选择性环磷酸鸟苷磷酸二酯酶抑制在M&B 22,948、MY-5445、长春西汀和1-甲基-3-异丁基-8-(甲氨基)黄嘌呤肌松作用中的作用

Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.

作者信息

Souness J E, Brazdil R, Diocee B K, Jordan R

机构信息

Research Institute, Rhône-Poulenc Ltd., Dagenham, Essex.

出版信息

Br J Pharmacol. 1989 Nov;98(3):725-34. doi: 10.1111/j.1476-5381.1989.tb14599.x.

Abstract
  1. The mechanism by which M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine (MIMAX), which have been described as selective cyclic GMP phosphodiesterase (PDE) inhibitors, relax rat aorta was investigated. 2. Three cyclic nucleotide PDEs were identified in the soluble fraction of rat aorta; a Ca2+-insensitive form exhibiting substrate selectivity for cyclic GMP (cGMP PDE), a Ca2+/calmodulin-stimulated form which also preferentially hydrolyzed cyclic GMP (Ca2+ PDE), and a form demonstrating substrate selectivity for cyclic AMP (cAMP PDE). 3. M&B 22,948 and MIMAX inhibited cGMP PDE (Ki = 0.16 microM and 0.43 microM, respectively) and Ca2+ PDE (Ki = 9.9 microM and 0.55 microM, respectively), but exhibited weak activity against cAMP PDE (Ki = 249 microM and 42 microM, respectively). MY-5445 selectivity inhibited cGMP PDE (Ki = 1.3 microM) and vinpocetine selectively inhibited Ca2+ PDE (Ki = 14 microM). 4. M&B 22,948 and MIMAX induced dose-dependent increases in the accumulation of cyclic GMP, but not cyclic AMP, in rat aorta pieces. These effects were greatly reduced by endothelial denudation and by methylene blue (5 microM) which blocks the actions of endothelium-derived relaxant factor. MY-5445 and vinpocetine had no effect on rat aorta cyclic GMP or cyclic AMP accumulation. 5. All four compounds caused dose-related relaxation of 5-hydroxytryptamine (10 microM) contracted, endothelium-intact rat aorta, the effects of M&B 22,948 and MIMAX being greatly reduced by methylene blue (5 microM). Methylene blue also caused 10 fold and 100 fold rightward shifts in the dose-response curves of MY-5445 and vinpocetine, respectively. 6. The results are consistent with the smooth muscle relaxant actions of M&B 22,948 and MIMAX, but not vinpocetine and MY-5445, being mediated through a mechanism involving inhibition of cyclic GMP hydrolysis.
摘要
  1. 研究了曾被描述为选择性环鸟苷酸磷酸二酯酶(PDE)抑制剂的M&B 22,948、MY-5445、长春西汀和1-甲基-3-异丁基-8-(甲氨基)黄嘌呤(MIMAX)使大鼠主动脉舒张的机制。2. 在大鼠主动脉的可溶部分鉴定出三种环核苷酸磷酸二酯酶;一种对钙不敏感的形式,对环鸟苷酸(cGMP PDE)表现出底物选择性,一种钙/钙调蛋白刺激的形式,也优先水解环鸟苷酸(Ca2+ PDE),以及一种对环腺苷酸表现出底物选择性的形式(cAMP PDE)。3. M&B 22,948和MIMAX抑制cGMP PDE(Ki分别为0.16微摩尔和0.43微摩尔)和Ca2+ PDE(Ki分别为9.9微摩尔和0.55微摩尔),但对cAMP PDE表现出较弱的活性(Ki分别为249微摩尔和42微摩尔)。MY-5445选择性抑制cGMP PDE(Ki = 1.3微摩尔),长春西汀选择性抑制Ca2+ PDE(Ki = 14微摩尔)。4. M&B 22,948和MIMAX使大鼠主动脉条中环鸟苷酸而非环腺苷酸的积累呈剂量依赖性增加。这些作用因内皮剥脱和亚甲蓝(5微摩尔)而大大降低,亚甲蓝可阻断内皮源性舒张因子的作用。MY-5445和长春西汀对大鼠主动脉中环鸟苷酸或环腺苷酸的积累没有影响。5. 所有四种化合物均使5-羟色胺(10微摩尔)收缩的、内皮完整的大鼠主动脉产生剂量相关的舒张,M&B 22,948和MIMAX的作用因亚甲蓝(5微摩尔)而大大降低。亚甲蓝还分别使MY-5445和长春西汀的剂量-反应曲线向右移动10倍和100倍。6. 结果表明,M&B 22,948和MIMAX的平滑肌舒张作用,但长春西汀和MY-5445的平滑肌舒张作用并非如此,是通过一种涉及抑制环鸟苷酸水解的机制介导的。

相似文献

引用本文的文献

1
Phosphodiesterase in heart and vessels: from physiology to diseases.心脏和血管中的磷酸二酯酶:从生理学到疾病。
Physiol Rev. 2024 Apr 1;104(2):765-834. doi: 10.1152/physrev.00015.2023. Epub 2023 Nov 16.
3
An update on vinpocetine: New discoveries and clinical implications.文尼帕汀:新发现与临床意义的更新。
Eur J Pharmacol. 2018 Jan 15;819:30-34. doi: 10.1016/j.ejphar.2017.11.041. Epub 2017 Nov 26.
4
Cyclic nucleotide phosphodiesterase 1 and vascular aging.环核苷酸磷酸二酯酶1与血管衰老
Clin Sci (Lond). 2015 Dec;129(12):1077-81. doi: 10.1042/CS20150605. Epub 2015 Sep 15.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验